Finance

Beta
Lists
TXG:NASDAQ
10X Genomics Inc
$34.77
-2.69%
(-0.96) 1D
Jun 26, 3:09:53 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TXG...
Open
$35.51
High
$36.66
Low
$34.57
Mkt. cap
4.41B
Avg. vol.
3.21M
Volume
1.13M
52-wk high
$36.88
52-wk low
$11.16
EPS
-$0.17
Beta
2.12
Shares outstanding
116.88M
No. of employees
1K
Open
$35.51
High
$36.66
Low
$34.57
Mkt. cap
4.41B
Avg. vol.
3.21M
Volume
1.13M
52-wk high
$36.88
52-wk low
$11.16
EPS
-$0.17
Beta
2.12
Shares outstanding
116.88M
No. of employees
1K
News stories
From sources across the web
Profile
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics. Wikipedia
About 10X Genomics Inc
CEOSerge Saxonov
Employees1.18K
Founded2012
HeadquartersPleasanton, California, United States
SectorHealth care
Website10xgenomics.com
Analyst ratings
Based on 10 analysts giving stock ratings to TXG in the past 3 months
Buy
Buy
3
Hold
7
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for TXG in the last 3 months.
Highest
Current $34.77
$40.00 (+15.04%)
Average
$25.75 (-25.94%)
Lowest
$20.00 (-42.48%)
Analyst
Recommendation
Action
Price target
Projected
Date
Luke Sergott
Barclays
Buy
Reiterated
$40.00
+15%
06/24/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Reiterated
$32.00
-8%
06/10/2026
Michael Ryskin
Bank of America Securities
Hold
Maintained
-
-
05/14/2026
Kallum Titchmarsh
Morgan Stanley
Hold
Maintained
$22.00
-36.7%
05/12/2026
Casey Woodring
J.P. Morgan
Hold
Maintained
$20.00
-42.5%
05/12/2026
Matt Larew
William Blair
Buy
Maintained
-
-
05/08/2026
Justin Bowers
Deutsche Bank
Hold
Maintained
$23.00
-33.9%
05/08/2026
David Westenberg
Piper Sandler
Hold
Maintained
$20.00
-42.5%
05/08/2026
Daniel Brennan
TD Cowen
Hold
Maintained
$25.00
-28.1%
05/07/2026
Patrick B Donnelly
Citi
Hold
Reiterated
$24.00
-31%
04/07/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
$25.00
-28.1%
03/02/2026
Dan Leonard
RBC Capital
Hold
Maintained
$20.00
-42.5%
02/19/2026
Tycho Peterson
Jefferies
Buy
Reiterated
$21.00
-39.6%
02/13/2026
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.07 / -$0.06
+219.15%beat
Revenue / Est. (USD)
150.84M / 146.85M
+2.72%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
172.91M
149.00M
166.03M
150.84M
Cost of goods sold
47.42M
48.70M
52.88M
44.66M
Cost of revenue
47.42M
48.70M
52.88M
44.66M
Research and development expenses
57.32M
57.19M
55.77M
56.85M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
72.71M
74.66M
73.02M
66.38M
Operating expense
130.04M
131.85M
128.79M
123.22M
Total operating expenses
177.46M
180.54M
181.67M
167.89M
Operating income
-4.55M
-31.54M
-15.64M
-17.05M
Other non operating income
2.60M
538.00K
-3.04M
-72.00K
EBT including unusual items
37.00M
-28.20M
-15.19M
-12.85M
EBT excluding unusual items
2.32M
-26.40M
-12.39M
-12.90M
Income tax expense
2.46M
-733.00K
1.06M
623.00K
Effective tax rate
6.65%
2.60%
-6.97%
-4.85%
Other operating expenses
-
-
-
-
Net income
34.54M
-27.47M
-16.25M
-13.47M
Net profit margin
19.97%
-18.44%
-9.79%
-8.93%
Earnings per share
0.48
-0.02
0.07
0.07
Interest and investment income
4.27M
5.20M
6.89M
5.01M
Interest expense
-3.00K
-
-
-
Net interest expenses
4.27M
5.20M
6.89M
5.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.26M
-21.24M
-5.58M
-7.09M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of TXG
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer